DC
ECYT

Deere & Company’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Deere & Company’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-71,518
Closed -$222K – 1153
2016
Q1 		$222K Buy
+71,518
New +$233K 0.01% 899

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deere & Company's ECYT Position: Q2 2016 in Review

Deere & Company sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2016, closing a stake of 71,518 shares — an estimated $222K sold.

Deere & Company first reported a position in ECYT in Q1 2016 and held it in 1 quarter. The position peaked at $222K in Q1 2016. 96 funds tracked by Wall St. Rank hold ECYT as of Q2 2016.

  • Deere & Company reported no remaining Endocyte, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Deere & Company sold 71,518 Endocyte, Inc. Common Stock shares in Q2 2016, an estimated $222K.
  • Deere & Company first reported a position in Endocyte, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Deere & Company's Endocyte, Inc. Common Stock position peaked at $222K in Q1 2016.
  • 96 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2016.

Based on Deere & Company's 13F filing for Q2 2016, filed 11 Aug 2016.